Serveur d'exploration Covid - Exploration (Accueil)

Index « AbsEn.i » - entrée « compounds »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
compounded < compounds < comprehend  Facettes :

List of bibliographic references indexed by compounds

Number of relevant bibliographic references: 56.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000132 (2020) Jrhau Lung [Taïwan] ; Yu-Shih Lin [Taïwan] ; Yao-Hsu Yang [Taïwan] ; Yu-Lun Chou ; Li-Hsin Shu [Taïwan] ; Yu-Ching Cheng [Taïwan] ; Hung Te Liu [Taïwan] ; Ching-Yuan Wu [Taïwan]The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase.
000213 (2020) Anh-Tien Ton [Canada] ; Francesco Gentile [Canada] ; Michael Hsing [Canada] ; Fuqiang Ban [Canada] ; Artem Cherkasov [Canada]Rapid Identification of Potential Inhibitors of SARS-CoV-2 Main Protease by Deep Docking of 1.3 Billion Compounds.
000243 (2020) Francesco Di Pierro [Oman] ; Alexander Bertuccioli [Italie] ; Ilaria Cavecchia [Italie]Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus.
000290 (2020) S K Kritas [Grèce] ; G. Ronconi [Italie] ; Al Caraffa [Italie] ; C E Gallenga [Italie] ; R. Ross [États-Unis] ; P. Conti [Italie]Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy.
000470 (2020) Miguel Angel Martinez [Espagne]Compounds with therapeutic potential against novel respiratory 2019 coronavirus.
000632 (2019) Mohammed Albratty [Arabie saoudite] ; Karam Ahmed El-Sharkawy [Arabie saoudite] ; Hassan Ahmed Alhazmi [Arabie saoudite]Synthesis and evaluation of some new 1,3,4-oxadiazoles bearing thiophene, thiazole, coumarin, pyridine and pyridazine derivatives as antiviral agents.
000645 (2019) Belén Martínez-Gualda [Espagne] ; Liang Sun [Belgique] ; Olaia Martí-Marí [Espagne] ; Carmen Mirabelli [Belgique] ; Leen Delang [Belgique] ; Johan Neyts [Belgique] ; Dominique Schols [Belgique] ; María-José Camarasa [Espagne] ; Ana San-Félix [Espagne]Modifications in the branched arms of a class of dual inhibitors of HIV and EV71 replication expand their antiviral spectrum.
000758 (2017) Karima Ighilahriz-Boubchir [Algérie] ; Baya Boutemeur-Kheddis ; Cherifa Rabia ; Malika Makhloufi-Chebli [Algérie] ; Maamar Hamdi ; Artur M. S. SilvaRecyclable Keggin Heteropolyacids as an Environmentally Benign Catalyst for the Synthesis of New 2-Benzoylamino-N-phenyl-benzamide Derivatives under Microwave Irradiations at Solvent-Free Conditions and the Evaluation of Biological Activity
000818 (2017) Ujjini H. Manjunatha ; Sumiti Vinayak [États-Unis] ; Jennifer A. Zambriski [États-Unis] ; Alexander T. Chao ; Tracy Sy [États-Unis] ; Christian G. Noble ; Ghislain M. C. Bonamy ; Ravinder R. Kondreddi ; Bin Zou ; Peter Gedeck ; Carrie F. Brooks [États-Unis] ; Gillian T. Herbert [États-Unis] ; Adam Sateriale [États-Unis] ; Jayesh Tandel [États-Unis] ; Susan Noh [États-Unis] ; Suresh B. Lakshminarayana ; Siau H. Lim ; Laura B. Goodman [États-Unis] ; Christophe Bodenreider ; Gu Feng ; Lijun Zhang [République populaire de Chine] ; Francesca Blasco ; Juergen Wagner ; F. Joel Leong ; Boris Striepen [États-Unis] ; Thierry T. DiaganaA Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis
000824 (2016) Iwona E. Głowacka ; Rafał Gulej ; Piotr Grzonkowski ; Graciela Andrei ; Dominique Schols ; Robert Snoeck ; Dorota G. PiotrowskaSynthesis and the Biological Activity of Phosphonylated 1,2,3-Triazolenaphthalimide Conjugates
000841 (2016) Dorota G. Piotrowska ; Graciela Andrei ; Dominique Schols ; Robert Snoeck ; Magdalena Grabkowska-Dru YcNew Isoxazolidine-Conjugates of Quinazolinones—Synthesis, Antiviral and Cytostatic Activity
000865 (2016) Sushanto Gouda [Inde] ; Gitishree Das [Corée du Sud] ; Sandeep K. Sen [Inde] ; Han-Seung Shin [Corée du Sud] ; Jayanta Kumar Patra [Corée du Sud]Endophytes: A Treasure House of Bioactive Compounds of Medicinal Importance
000895 (2016) Abdo A. Elfiky [Égypte, Italie]Zika viral polymerase inhibition using anti‐HCV drugs both in market and under clinical trials
000896 (2016) Eyüp Ba Aran [Turquie] ; Ay Egül Karaküçük-Iyido An [Turquie] ; Dominique Schols [Belgique] ; Emine Elçin Oruç-Emre [Turquie]Synthesis of Novel Chiral Sulfonamide‐Bearing 1,2,4‐Triazole‐3‐thione Analogs Derived from D‐ and L‐Phenylalanine Esters as Potential Anti‐Influenza Agents
000897 (2016) Tarek S. Ibrahim [Égypte] ; Amany M. M. Al-Mahmoudy [Égypte] ; Mohamed Elagawany [Égypte] ; Mohamed A. Ibrahim [Arabie saoudite, Égypte] ; Siva S. Panda [États-Unis]Synthesis and Antiviral Bioassay of New Diphenyl Ether‐based Compounds
000904 (2016) Abdelaaziz Ouahrouch [Maroc, Allemagne] ; Moha Taourirte [Maroc] ; Dominique Schols [Belgique] ; Robert Snoeck [Belgique] ; Graciela Andrei [Belgique] ; Joachim W. Engels [Allemagne] ; Hassan B. Lazrek [Maroc]Design, Synthesis, and Antiviral Activity of Novel Ribonucleosides of 1,2,3‐Triazolylbenzyl‐aminophosphonates
000930 (2015) Iwona E. Głowacka ; Graciela Andrei ; Dominique Schols ; Robert Snoeck ; Dorota G. PiotrowskaPhosphonylated Acyclic Guanosine Analogues with the 1,2,3-Triazole Linker
000952 (2015) Caiao Guo ; Liang Ma ; Yudan Zhao ; Anlin Peng ; Biao Cheng ; Qiaoqiao Zhou ; Ling Zheng ; Kun HuangInhibitory effects of magnolol and honokiol on human calcitonin aggregation
000966 (2015) John Gnabre [États-Unis] ; Robert Bates [États-Unis] ; Ru Chih Huang [États-Unis]Creosote bush lignans for human disease treatment and prevention: Perspectives on combination therapy
000A38 (2014) Emilia Bankowska [Pologne] ; Jan Balzarini [Belgique] ; Iwona E. Głowacka [Pologne] ; Andrzej E. Wr Blewski [Pologne]Design, synthesis, antiviral and cytotoxic evaluation of novel acyclic phosphonate nucleotide analogues with a 5,6-dihydro-1H-[1,2,3]triazolo[4,5-d]pyridazine-4,7-dione system
000A47 (2014) Adeyemi O. Adedeji [États-Unis] ; Stefan G. Sarafianos [États-Unis]Antiviral Drugs Specific for Coronaviruses in Preclinical Development

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "compounds" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "compounds" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    compounds
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Fri Mar 27 18:14:15 2020. Site generation: Sun Jan 31 15:15:08 2021